Barry J. Simon, an insider at ImmunityBio, Inc. (IBRX), sold 165,000 shares of the company's common stock on February 24, 2026. The transaction was executed at a price of $10.25 per share, totaling approximately $1,691,250.

This transaction follows several other recent sales by Mr. Simon. In February 2026 alone, he also sold 10,000 shares on February 20. Additionally, in January 2026, Mr. Simon divested a total of 151,967 shares across two separate transactions. Another insider, Christobel Selecky, also sold 25,000 shares on February 23, 2026.

Insider sales can occur for various reasons, including personal financial planning, tax considerations, or portfolio diversification, and do not necessarily indicate a negative outlook on the company's future prospects.